RIPK2 and hepatocellular carcinoma: Based on the results of human studies, they also examined whether NOD2 promotes hepatocarcinogenesis in the DEN/CCl4 model and found that HCC and inflammation were significantly attenuated in mice with hepatocyte-specific NOD2 or RIPK2 knock-out mice (51).